What’s new and on the horizon in anticoagulation for prevention and treatment of VTE
56:25
Multi discipline team: Impossible cases in cancer associated thrombosis
56:07
Diagnosing DVT clinically – just as hard as ever!
1:02:34
Litigation & Business Strategies for 503A GLP-1 Compounding: Navigating Regulatory and Legal Risks
56:26
What's New in Antithrombotic Treatment of VTE Disease: ACCP (CHEST) Guidelines Update 2021
32:31
Dr. Jeffrey Weitz discusses Factor XI/XIa during the 32nd Congress
56:16
VTE and Movement
58:43
DOACs in extremes of body weight
38:36